247 related articles for article (PubMed ID: 35198466)
41. Treatment of DIHS/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir--a hypothesis.
Moling O; Tappeiner L; Piccin A; Pagani E; Rossi P; Rimenti G; Vedovelli C; Mian P
Med Sci Monit; 2012 Jul; 18(7):CS57-62. PubMed ID: 22739739
[TBL] [Abstract][Full Text] [Related]
42. Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
Takamiyagi S; Iriki H; Asahina Y; Furuichi Y; Funakoshi T; Ichikawa M; Mikami Y; Okita H; Sakiyama T; Inazumi T; Amagai M; Takahashi H
J Dermatol; 2022 Aug; 49(8):796-799. PubMed ID: 35502510
[TBL] [Abstract][Full Text] [Related]
43. Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms: Predictive Score and Outcomes.
Mizukawa Y; Hama N; Miyagawa F; Takahashi H; Ogawa Y; Kurata M; Asada H; Abe R; Shiohara T
J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3169-3178.e7. PubMed ID: 37437776
[TBL] [Abstract][Full Text] [Related]
44. A Case of Amoxicillin-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (Dress) Syndrome Associated With Significant Reactive Hypereosinophilia (HE): A Case Report.
Oh J; Singh A; Fonseca M; Muppidi M
Cureus; 2023 Jul; 15(7):e41646. PubMed ID: 37565132
[TBL] [Abstract][Full Text] [Related]
45. Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea.
Lee JY; Lee SY; Hahm JE; Ha JW; Kim CW; Kim SS
Int J Dermatol; 2017 Sep; 56(9):944-951. PubMed ID: 28718873
[TBL] [Abstract][Full Text] [Related]
46. Drug-induced hypersensitivity syndrome with myocardial involvement treated with tofacitinib.
Damsky WE; Vesely MD; Lee AI; Choi J; Meyer AC; Chen M; Ahmad T; King B
JAAD Case Rep; 2019 Dec; 5(12):1018-1026. PubMed ID: 31763425
[No Abstract] [Full Text] [Related]
47. Clinical, biochemical, and serologic predictors of drug reaction with eosinophilia and systemic symptoms syndrome: A prospective case-control study.
Choudhary R; Vinay K; Srivastava N; Bishnoi A; Kamat D; Parsad D; Bhatia A; Kumaran MS
J Am Acad Dermatol; 2021 Oct; 85(4):901-909. PubMed ID: 33785387
[TBL] [Abstract][Full Text] [Related]
48. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS).
Ogawa K; Morito H; Hasegawa A; Daikoku N; Miyagawa F; Okazaki A; Fukumoto T; Kobayashi N; Kasai T; Watanabe H; Sueki H; Iijima M; Tohyama M; Hashimoto K; Asada H
J Dermatol Sci; 2013 Jan; 69(1):38-43. PubMed ID: 23141052
[TBL] [Abstract][Full Text] [Related]
49. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature, with a focus on relapsing cases.
Afiouni R; Zeinaty P; Kechichian E; Zoghaib S; Matar S; Helou-Mallat J; Tomb R
Pediatr Dermatol; 2021 Jan; 38(1):125-131. PubMed ID: 33155729
[TBL] [Abstract][Full Text] [Related]
50. Chemokines in Severe Cutaneous Adverse Reactions (SCARs).
Miyagawa F; Asada H
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34204146
[TBL] [Abstract][Full Text] [Related]
51. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature.
Metterle L; Hatch L; Seminario-Vidal L
Pediatr Dermatol; 2020 Jan; 37(1):124-129. PubMed ID: 31691347
[TBL] [Abstract][Full Text] [Related]
52. Pulmonary Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review.
Taweesedt PT; Nordstrom CW; Stoeckel J; Dumic I
Biomed Res Int; 2019; 2019():7863815. PubMed ID: 31662996
[TBL] [Abstract][Full Text] [Related]
53. Unraveling the complexities of drug reaction with eosinophilia and systemic symptoms (DRESS): Insights into clinical, laboratory, and histopathologic features of a case series from an Italian tertiary center.
Schroeder JW; Napoli C; Caputo V; Bonoldi E; Rongioletti F
Clin Dermatol; 2023; 41(6):721-728. PubMed ID: 37730074
[TBL] [Abstract][Full Text] [Related]
54. The DRESS syndrome: a literature review.
Cacoub P; Musette P; Descamps V; Meyer O; Speirs C; Finzi L; Roujeau JC
Am J Med; 2011 Jul; 124(7):588-97. PubMed ID: 21592453
[TBL] [Abstract][Full Text] [Related]
55. Pustular-type drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement.
Matsuda H; Saito K; Takayanagi Y; Okazaki T; Kashima K; Ishikawa K; Kai Y; Takeo N; Hatano Y; Okamoto O; Fujiwara S
J Dermatol; 2013 Feb; 40(2):118-22. PubMed ID: 23216243
[TBL] [Abstract][Full Text] [Related]
56. Vemurafenib- and Cobimetinib-Associated Drug Reaction With Eosinophilia and Systemic Symptoms in a Patient With Metastatic Melanoma.
Al-Saedy M; Al-Saedy S; Rieck C
Cureus; 2023 Aug; 15(8):e44462. PubMed ID: 37664366
[TBL] [Abstract][Full Text] [Related]
57. Advanced human immunodeficiency virus (HIV) does not affect ability to utilize lymphadenopathy in assessment of drug reaction with eosinophilia and systemic symptoms syndrome in HIV and tuberculosis: Prospective comparative study.
Machona MS; Muloiwa R; Porter M; Peter J; Lehloenya RJ
J Allergy Clin Immunol Glob; 2024 Aug; 3(3):100276. PubMed ID: 38946893
[TBL] [Abstract][Full Text] [Related]
58. A typical presentation of moxifloxacin-induced DRESS syndrome with pulmonary involvement: a case report and review of the literature.
Zhang Y; Wang X; Cheng Y; Wang X; Zhang Y
BMC Pulm Med; 2022 Jul; 22(1):279. PubMed ID: 35854287
[TBL] [Abstract][Full Text] [Related]
59. Drug reaction with eosinophilia and systemic symptoms: observations from a tertiary care institution.
Sasidharanpillai S; Riyaz N; Rajan U; Binitha MP; Khader A; Mariyath OK; John R; Puravoor J
Indian J Dermatol Venereol Leprol; 2014; 80(3):221-8. PubMed ID: 24823399
[TBL] [Abstract][Full Text] [Related]
60. Vancomycin-associated drug-induced hypersensitivity syndrome.
Madigan LM; Fox LP
J Am Acad Dermatol; 2019 Jul; 81(1):123-128. PubMed ID: 30738120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
